Plasminogen Activation on Tumor Cell Surface and its Involvement in Human Leukemia

作者: Hannele Tapiovaara , Riitta Alitalo , Antti Vaheri

DOI: 10.1016/S0065-230X(08)60861-1

关键词:

摘要: Publisher Summary This chapter focuses on the plasminogen activation tumor cell surface and its involvement in human leukemia. The function of activators (PAS) plasmin adult organism has been mainly related to fibrinolysis, tissue remodeling, migration, destruction. Associated with activity is dissolution blood clots, inflammation, dissemination, wound healing, angiogenesis, trophoblast invasion. In addition directly cleaving components extracellular matrix, able regulate various functions through prohormones latent growth factors. invasive capacity cells requires proteolytic activity; therefore, plasmin, together other tissue-destructive enzymes, implicated property metastasize. Both PAS bind surfaces, this allows generation at restricted areas cell-matrix interface. High levels urokinase activator (uPA) and/or inhibitor type 1, seem indicate an adverse prognosis for patients cancer, as was first shown case breast cancer. described include plasminogen, urokinase-type activator, tissue-type activator. Plasminogen regulated both by inhibitors plasmin. (PAIs) are specific, fast-acting PAS. Four known, PAI-1, PAI-2, PAI-3, PAI-4 (protease nexin). α 2 MR, which identical low-density lipoprotein receptor protein (LRP), reported mediate internalization degradation tPA, tPA-PAI-1 complexes, uPA-PAL1 uPA-protease nexin complexes. Although needed process matrix destruction, it still unknown whether uPA or merely antigen uPAR involved migration.

参考文章(314)
Raymund Machovich, Whyte G. Owen, An elastase-dependent pathway of plasminogen activation Biochemistry. ,vol. 28, pp. 4517- 4522 ,(1989) , 10.1021/BI00436A059
Guohui Liu, Marc A. Shuman, Robert L. Cohen, Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells International Journal of Cancer. ,vol. 60, pp. 501- 506 ,(1995) , 10.1002/IJC.2910600413
Mario Gonzalez-Gronow, Jay M. Edelberg, Salvatore V. Pizzo, Further characterization of the cellular plasminogen binding site: evidence that plasminogen 2 and lipoprotein a compete for the same site. Biochemistry. ,vol. 28, pp. 2374- 2377 ,(1989) , 10.1021/BI00432A005
E. Pujade-Lauraine, H. Lu, S. Mirshahi, J. Soria, C. Soria, A. Bernadou, E. K. O. Kruithof, H. R. Lijnen, P. Burtin, The plasminogen-activation system in ovarian tumors. International Journal of Cancer. ,vol. 55, pp. 27- 31 ,(1993) , 10.1002/IJC.2910550106
Robert L. O'Grady, Linda I. Upfold, Ross W. Stephens, Rat mammary carcinoma cells secrete active collagenase and activate latent enzyme in the stroma via plasminogen activator International Journal of Cancer. ,vol. 28, pp. 509- 515 ,(1981) , 10.1002/IJC.2910280418
P H Quax, G N van Muijen, E J Weening-Verhoeff, L R Lund, K Danø, D J Ruiter, J H Verheijen, Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation. Journal of Cell Biology. ,vol. 115, pp. 191- 199 ,(1991) , 10.1083/JCB.115.1.191
Fritz Jänicke, Manfred Schmitt, Lothar Pache, Kurt Ulm, Nadia Harbeck, Heinz Höfler, Henner Graeff, Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer Breast Cancer Research and Treatment. ,vol. 24, pp. 195- 208 ,(1993) , 10.1007/BF01833260
C. W. Crowley, R. L. Cohen, B. K. Lucas, G. Liu, M. A. Shuman, A. D. Levinson, Prevention of metastasis by inhibition of the urokinase receptor Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 5021- 5025 ,(1993) , 10.1073/PNAS.90.11.5021
L Ossowski, G Clunie, M T Masucci, F Blasi, In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion. Journal of Cell Biology. ,vol. 115, pp. 1107- 1112 ,(1991) , 10.1083/JCB.115.4.1107
Matti Höyhtyä, Erkki Hujanen, Taina Turpeenniemi-Hujanen, Unnur Thorgeirsson, Lance A. Liotta, Karl Tryggvason, Modulation of type-IV collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type-IV collagenase. International Journal of Cancer. ,vol. 46, pp. 282- 286 ,(1990) , 10.1002/IJC.2910460224